Putative Role of Dihydropyrimidine Dehydrogenase in the Toxic Side Effect of 5-Fluorouracil in Colorectal Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|55|5|468-474

ISSN： 0030-2414

Source： Oncology, Vol.55, Iss.5, 1998-08, pp. : 468-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predictive Role of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase and Thymidine Phosphorylase Expression in Colorectal Cancer Patients Receiving Adjuvant 5-Fluorouracil

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 366-377

Karger

Access to resources Recommend Favorite

The Role of 5-Fluorouracil (5-FU) Reintroduction with Irinotecan or Oxaliplatin in Truly 5-FU-Refractory Advanced Colorectal Cancer Patients

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Combined Irinotecan, Oxaliplatin and 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 254-265

Karger

Access to resources Recommend Favorite

Irinotecan and Mitomycin C in 5-Fluorouracil-Refractory Colorectal Cancer Patients

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 127-133

Karger

Access to resources Recommend Favorite

Multiple Organ Failure due to 5-Fluorouracil Chemotherapy in a Patient with a Rare Dihydropyrimidine Dehydrogenase Gene Variant

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 559-562

Karger

Access to resources Recommend Favorite